Quarterly report · Q2

Period2023-09-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥13.9bn2023-09-01 → 2024-02-29Cons.Net sales
Revenue¥24.5bn2022-09-01 → 2023-08-31Cons.Net sales (5-year summary)
Revenue¥12.0bn2022-09-01 → 2023-02-28Cons.Net sales
Operating income¥4.2bn2023-09-01 → 2024-02-29Cons.Operating income
Operating income¥3.5bn2022-09-01 → 2023-02-28Cons.Operating income
Ordinary income¥4.6bn2023-09-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥8.0bn2022-09-01 → 2023-08-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.5bn2022-09-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥4.5bn2023-09-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥3.6bn2022-09-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥3.2bn2023-09-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥6.0bn2022-09-01 → 2023-08-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.6bn2022-09-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥3.2bn2023-09-01 → 2024-02-29Cons.Profit loss
Net income¥2.6bn2022-09-01 → 2023-02-28Cons.Profit loss
Total assets¥56.2bnat 2024-02-29Cons.Assets
Total assets¥55.0bnat 2023-08-31Cons.Assets
Total assets¥50.7bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥4.6bnat 2024-02-29Cons.Liabilities
Total liabilities¥5.1bnat 2023-08-31Cons.Liabilities
Net assets / equity¥51.6bnat 2024-02-29Cons.Net assets
Net assets / equity¥49.8bnat 2023-08-31Cons.Net assets
Net assets / equity¥46.2bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥23.5bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥25.4bnat 2023-08-31Cons.Cash and deposits
Cash & equivalents¥22.7bnat 2024-02-29Cons.Cash and cash equivalents
Cash & equivalents¥23.8bnat 2023-08-31Cons.Cash and cash equivalents
Cash & equivalents¥21.4bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥22.1bnat 2022-08-31dCons.Cash and cash equivalents
Operating cash flow¥3.6bn2023-09-01 → 2024-02-29Cons.Net cash provided by used in operating activities
Operating cash flow¥8.0bn2022-09-01 → 2023-08-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.8bn2022-09-01 → 2023-02-28Cons.Net cash provided by used in operating activities
Investing cash flow−¥3.1bn2023-09-01 → 2024-02-29Cons.Net cash provided by used in investment activities
Investing cash flow−¥4.0bn2022-09-01 → 2023-08-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.6bn2022-09-01 → 2023-02-28Cons.Net cash provided by used in investment activities
Financing cash flow−¥2.1bn2023-09-01 → 2024-02-29Cons.Net cash provided by used in financing activities
Financing cash flow−¥3.3bn2022-09-01 → 2023-08-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.8bn2022-09-01 → 2023-02-28Cons.Net cash provided by used in financing activities
EPS (basic)¥32.412023-09-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥16.432023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.462022-09-01 → 2023-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥26.042022-09-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥12.842022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
Equity ratio91.8%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio90.6%at 2023-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio91.0%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 32
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-09-01 → 2024-02-29¥0
Reconciling Itemsreconcilingrevenue intersegment2023-09-01 → 2024-02-29¥0
jpcrp040300-q2r_E02340-000Dentalreportable segmentrevenue2023-09-01 → 2024-02-29¥5.1bn
jpcrp040300-q2r_E02340-000Dentalreportable segmentrevenue external2023-09-01 → 2024-02-29¥5.1bn
jpcrp040300-q2r_E02340-000Dentalreportable segmentsegment profit2023-09-01 → 2024-02-29¥1.0bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue2023-09-01 → 2024-02-29¥5.0bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue external2023-09-01 → 2024-02-29¥5.0bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue intersegment2023-09-01 → 2024-02-29¥0
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentsegment profit2023-09-01 → 2024-02-29¥1.9bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentrevenue2023-09-01 → 2024-02-29¥3.8bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentrevenue external2023-09-01 → 2024-02-29¥3.8bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentsegment profit2023-09-01 → 2024-02-29¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-09-01 → 2024-02-29¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-09-01 → 2024-02-29¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-09-01 → 2024-02-29¥0
Total Of Reportable Segments And Otherssegment totalsegment profit2023-09-01 → 2024-02-29¥4.2bn
Reconciling Itemsreconcilingrevenue2022-09-01 → 2023-02-28−¥1m
Reconciling Itemsreconcilingrevenue intersegment2022-09-01 → 2023-02-28−¥1m
jpcrp040300-q2r_E02340-000Dentalreportable segmentrevenue2022-09-01 → 2023-02-28¥4.7bn
jpcrp040300-q2r_E02340-000Dentalreportable segmentrevenue external2022-09-01 → 2023-02-28¥4.7bn
jpcrp040300-q2r_E02340-000Dentalreportable segmentsegment profit2022-09-01 → 2023-02-28¥1.3bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue2022-09-01 → 2023-02-28¥4.2bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue external2022-09-01 → 2023-02-28¥4.2bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue intersegment2022-09-01 → 2023-02-28¥1m
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentsegment profit2022-09-01 → 2023-02-28¥1.3bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentrevenue2022-09-01 → 2023-02-28¥3.2bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentrevenue external2022-09-01 → 2023-02-28¥3.2bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentsegment profit2022-09-01 → 2023-02-28¥917m
Total Of Reportable Segments And Otherssegment totalrevenue2022-09-01 → 2023-02-28¥12.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-09-01 → 2023-02-28¥12.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-09-01 → 2023-02-28¥1m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-09-01 → 2023-02-28¥3.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 520
ItemContextValueUnit
Cash and cash equivalentsPrior2YearInstant22084000000JPY
Cash and cash equivalentsPrior1YearInstant23798000000JPY
Cash and cash equivalentsPrior1QuarterInstant21358000000JPY
Cash and cash equivalentsCurrentQuarterInstant22677000000JPY
Salaries and allowances sgaPrior1YTDDuration755000000JPY
Salaries and allowances sgaCurrentYTDDuration998000000JPY
Provision for bonuses sgaPrior1YTDDuration239000000JPY
Provision for bonuses sgaCurrentYTDDuration254000000JPY
Retirement benefit expenses sgaPrior1YTDDuration40000000JPY
Retirement benefit expenses sgaCurrentYTDDuration31000000JPY
Research and development expenses sgaPrior1YTDDuration1002000000JPY
Research and development expenses sgaCurrentYTDDuration1125000000JPY
Depreciation sgaPrior1YTDDuration169000000JPY
Depreciation sgaCurrentYTDDuration178000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember3182000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember4154000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember4688000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember12025000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration12025000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember1000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-1000000JPY
Transactions with other segmentsPrior1YTDDuration-JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember3182000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember4155000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember4688000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember12026000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-1000000JPY
Net salesPrior1YTDDuration12025000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember917000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember1281000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember1255000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember3453000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-JPY
Operating incomePrior1YTDDuration3453000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember3786000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember4974000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember5147000000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember13908000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersCurrentYTDDuration13908000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember0JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember0JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-0JPY
Transactions with other segmentsCurrentYTDDuration-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-08-31pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-08-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-09-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-09-01/2024-02-29pass
statement vs summary · operating cash flowconsolidated 2022-09-01/2023-02-28pass
statement vs summary · operating cash flowconsolidated 2023-09-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-09-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-09-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-08-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass